Pilot study of zirconium-89 bevacizumab positron emission tomography for imaging angiogenesis in patients with inflammatory breast carcinoma receiving preoperative chemotherapy

被引：0
|
作者：
Jacene, H. A.
Overmoyer, B.
Schlosnagle, E. J.
Abbott, A.
Yeh, E.
Paolino, J.
Goel, S.
Culhane, A.
Bellon, J. R.
Nakhlis, F.
Hirshfield-Bartek, J.
Van den Abbeele, A.
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-OT2-02-03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OT2-02-03
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Phase II and fluorodeoxyglucose positron emission tomography (FDG-PET) study in patients with advanced biliary tract cancers (BTCs) receiving bevacizumab (B) in combination with gemcitabine (GEM) and oxaliplatin (OX)
    Zhu, A. X.
    Meyerhardt, J. A.
    Blaszkowsky, L. S.
    Muzikansky, A.
    Abrams, T. A.
    Chan, J. A.
    Enzinger, P. C.
    Bhargava, P.
    Kwak, E. L.
    Sahani, D. V.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [42] Preliminary results of a prospective pilot study, assessing imaging performance of 89Zirconium-labelled Girentuximab PET- CT in metastatic triple negative breast cancer patients
    Heymann, M. F.
    Mallet, A.
    Picot-Dilly, E.
    Le Thiec, M.
    Taupin, M.
    Mouton, A.
    Frenel, J. S.
    Bourbouloux, E.
    Allam, N.
    Ravasi, L.
    Ferrer, L.
    Kraeber-Bodere, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S151 - S151
  • [43] Tumor Hypoxia Detected by Positron Emission Tomography with 60Cu-ATSM as a Predictor of Response and Survival in Patients Undergoing Neoadjuvant Chemoradiotherapy for Rectal Carcinoma: A Pilot Study
    Dietz, David W.
    Dehdashti, Farrokh
    Grigsby, Perry W.
    Malyapa, Robert S.
    Myerson, Robert J.
    Picus, Joel
    Ritter, Jon
    Lewis, Jason S.
    Welch, Michael J.
    Siegel, Barry A.
    DISEASES OF THE COLON & RECTUM, 2008, 51 (11) : 1641 - 1648
  • [44] Simultaneous positron emission tomography with 18F-fluorodeoxyglucose with magnetic resonance imaging enterography for monitoring activity of inflammation in patients with Crohn's disease: a pilot study
    Beiderwellen, K.
    Gomez, B.
    Heusch, P.
    Gerken, G.
    Ruenzi, M.
    Bockisch, A.
    Lauenstein, T.
    Langhorst, J.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S164 - S164
  • [45] Gallium-68-avß3-Integrin Antagonist Peptidomimetic (Ga-68 avß3-IAC) Positron Emission Tomography for Imaging and Staging of Patients with Breast Cancer: A Pilot Study.
    Satz, Roseanne
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [46] TITLE: A pilot study of 89Zr-DFO-REGN3767 anti-LAG-3 antibody Positron Emission Tomography in Patients with Diffuse large B-cell lymphoma.
    Pandit-Taskar, Neeta
    Shutian, Ruan
    Grkovski, Milan
    Schwartz, Jazmin
    Lyashchenko, Serge
    Cheung, Kam
    Uldrick, Thomas
    Ma, Dangshe
    Giurleo, Jason
    Palomba, Lia
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [47] ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD--L1 with 89Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocol
    Hegi-Johnson, Fiona
    Rudd, Stacey E.
    Wichmann, Christian
    Akhurst, Tim
    Roselt, Peter
    Trinh, Jenny
    John, Thomas
    Devereux, Lisa
    Donnelly, Paul S.
    Hicks, Rod
    Scott, Andrew M.
    Steinfort, Daniel
    Fox, Stephen
    Blyth, Benjamin
    Parakh, Sagun
    Hanna, Gerard G.
    Callahan, Jason
    Burbury, Kate
    MacManus, Michael
    BMJ OPEN, 2022, 12 (11):
  • [48] Quantitative comparison between single-photon emission computed tomography and positron emission tomography imaging of lung ventilation with 99mTc-technegas and 68Ga-gallgas in patients with chronic obstructive pulmonary disease: A pilot study
    Cuna, Enrique Gustavo
    Pablo Gambini, Juan
    Servente, Liliana
    Savio, Eduardo
    William Engler, Henry
    Adrian Gonzalez, Gabriel
    Alonso, Omar
    WORLD JOURNAL OF NUCLEAR MEDICINE, 2019, 18 (03) : 251 - 257
  • [49] Molecular imaging of programmed death ligand 1 (PD-L1) expression with [89Zr]Zr-atezolizumab positron emission tomography/computed tomography (PET/CT) in patients with metastatic triple negative breast cancer (mTNBC): The MIMIR-study
    Altena, R.
    Tzortzakakis, A.
    Blomgren, A.
    Jussing, E.
    Ekman, S.
    Tran, T.
    Axelsson, R.
    Bergh, J.
    ANNALS OF ONCOLOGY, 2024, 35 : S402 - S403
  • [50] 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) as early imaging biomarker of axillary sentinel lymph node (SLN) status in locally advanced node-positive breast cancer (NPBC) patients (pts) receiving neoadjuvant chemotherapy (NACT)
    Dockx, Yanina
    Huizing, Manon Thirza
    Van den Wyngaert, Tim
    Altintas, Sevilay
    Huyghe, Ivan
    Geboers, Inge
    Vervliet, Johan
    Molderez, Christoph
    van Goethem, Mireille
    van Marck, Veerle
    Sonnemans, Hetty
    Tjalma, Wiebren
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345